Skip to content

Author

Se Joon Woo

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Real-World Safety and Effectiveness of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis: A Post-Marketing Surveillance Study in Korea.

PURPOSE This post-marketing surveillance study reports the real-world safety and effectiveness of adalimumab (Humira®, AbbVie Inc.) among patients with non-infectious intermediate, posterior, or panuveitis (NIIPPU) in Korea. METHODS The study was conducted at 17 medical centres from January 2018 to July 2020. Safety...

Seung-Woo Choi, Eun Jeen Ryu, Se Joon Woo · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.